Physician profile
Chad R Ritch
NPI 1316106321
$18,773.83
in general payments reported to CMS, 2019-2025
21 companies · $5,290 in 2025
The $5,290 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $265 · 2021: $169 · 2022: $4,304 · 2023: $4,107 · 2024: $4,142 · 2025: $5,290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,525 · Honoraria: $4,000 · Food and Beverage: $3,778 · Gift: $179 · Education: $57.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,525.00 |
| Honoraria | $4,000.00 |
| Food and Beverage | $3,778.47 |
| Gift | $178.52 |
| Education | $57.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $6,714.38 | 2020-2025 | Jelmyto |
| Intuitive Surgical, INC. | $4,179.26 | 2019-2024 | Da Vinci Surgical System |
| Ferring Pharmaceuticals INC. | $3,922.72 | 2023-2025 | Adstiladrin |
| Pfizer INC. | $1,290.12 | 2019-2025 | |
| Janssen Biotech, INC. | $562.52 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Integra Lifesciences Corporation | $345.40 | 2019-2022 | |
| Immunitybio, INC. | $323.29 | 2025 | |
| Baxter Healthcare | $265.51 | 2022 | |
| Photocure INC | $231.23 | 2022-2023 | Cysview |
| Boston Scientific Corporation | $155.78 | 2019-2020 | |
| Axonics, INC. | $150.17 | 2023 | Bulkamid, Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $149.21 | 2023 | |
| Coloplast Corp | $127.24 | 2019 | |
| Sumitomo Pharma America, INC. | $95.71 | 2023-2025 | Orgovyx, Gemtesa |
| Seagen INC. | $93.50 | 2023 | Padcev |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $77.68 | 2022 | |
| Abbvie INC. | $33.98 | 2019 | |
| Edap Technomed INC | $21.96 | 2025 | |
| Astellas Pharma US INC | $18.12 | 2023 | Myrbetriq |
| Antares Pharma, INC. | $16.05 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Ritch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.